Eczema Clinical Trials

15 studies are recruiting for eczema in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies now recruiting

1. Studies of Skin Microbes in Healthy People and in People With Skin Conditions

   This study will examine microbes (e.g., bacteria, fungi, viruses) that live on human skin and how microbes contribute to health and disease. It will analyze healthy human skin and how the these microorganisms might change in patients with atopic dermatitis (AD), a skin condition also known as eczem…

   Stage

   Not phased

   Ages

   2 to 100

   Site

   National Institutes of Health Clinical Center, Bethesda, Maryland

   Run by

   National Human Genome Research Institute (NHGRI)

   See if you can join NCT00605878 on ClinicalTrials.gov

2. Effects of Treatments on Atopic Dermatitis

   Background: - Atopic dermatitis, or eczema, is a chronic skin disorder. Patients sometimes have infections with S. aureus bacteria. Researchers want to study how eczema treatments affect the number and the type of bacteria on the skin. Objectives: - To study the effect of eczema treatments on skin …

   Stage

   Phase 2

   Ages

   2 to 50

   Site

   National Institutes of Health Clinical Center, Bethesda, Maryland

   Run by

   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

   See if you can join NCT01631617 on ClinicalTrials.gov

3. The Impact of Dietary Salt on the Severity of Eczema

   The goal of this clinical trial is to evaluate the feasibility of low-sodium diet to improve eczema severity. The main questions it aims to answer are: * Does a low-sodium diet improve eczema severity? * How does a low-sodium diet impact skin sodium concentration? * Is skin sodium concentration ass…

   Stage

   Phase 4

   Ages

   18 and older

   Site

   San Francisco VA Medical Center, San Francisco, California

   Locations

   2 in total

   Run by

   University of California, San Francisco

   See if you can join NCT07447063 on ClinicalTrials.gov

4. Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

   This is a first-in-human, Phase 1, double-blind, randomized, placebo-controlled, dose-escalation study evaluating ARQ-234. The study is designed to assess the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of ARQ-234 in two populations: healthy volunteers and participants wi…

   Stage

   Phase 1

   Ages

   18 to 65

   Site

   Clinical Site 106, Plainfield, Indiana

   Locations

   5 in total

   Run by

   Arcutis Biotherapeutics, Inc.

   See if you can join NCT07453602 on ClinicalTrials.gov

5. Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis

   Atopic dermatitis is well reported to have a significant impact on well-being in adolescents with atopic dermatitis, without clear recommendations for intervention. The investigators aim to identify an accessible, effective digital health intervention for these patients. The investigators hypothesi…

   Stage

   Not phased

   Ages

   13 to 17

   Site

   Weill Cornell Medicine, New York, New York

   Locations

   2 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT07746427 on ClinicalTrials.gov

6. A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

   This research study is being conducted to find out if the test medicine, abrocitinib, improves eczema and is safe for children 6 to <12 years of age who have moderate-to-severe eczema. Research study participants who meet the study criteria will be assigned by chance (like the flip of a coin) to re…

   Stage

   Phase 3

   Ages

   6 to 11

   Site

   Cahaba Dermatology & Skin Health Center, LLC, Birmingham, Alabama

   Locations

   46 in total

   Run by

   Pfizer

   See if you can join NCT06807268 on ClinicalTrials.gov

7. A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

   This is a Phase 2, two-stage, adaptive, 1:1 randomized, double-blind, vehicle-controlled clinical study evaluating the efficacy, safety, and tolerability of GX-03 topical ointment in adult subjects with atopic dermatitis (eczema). Stage 1 (Completed): Stage 1 comprised an initial cohort of 50 subje…

   Stage

   Phase 2

   Ages

   18 to 80

   Site

   ALS Global, Irving, Texas

   Run by

   Turn Therapeutics

   See if you can join NCT07355075 on ClinicalTrials.gov

8. A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

   This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.

   Stage

   Phase 2

   Ages

   18 to 65

   Site

   AllerVie Clinical Research, Birmingham, Alabama

   Locations

   85 in total

   Run by

   Apollo Therapeutics Ltd

   See if you can join NCT07599813 on ClinicalTrials.gov

9. Cardamom and Topical Roseomonas in Atopic Dermatitis

   Background: Atopic dermatitis (AD), also called eczema, is a chronic skin condition. AD can make skin dry and itchy, and sometimes it can lead to serious health problems, such as asthma, food allergies, eye infections, and sleep problems. No cure exists for AD. Researchers know that people with AD …

   Stage

   Phase 2

   Ages

   2 to 100

   Site

   National Institutes of Health Clinical Center, Bethesda, Maryland

   Run by

   National Institute of Allergy and Infectious Diseases (NIAID)

   See if you can join NCT06096857 on ClinicalTrials.gov

10. A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

    The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.

    Stage

    Phase 2

    Ages

    18 to 74

    Site

    Inmagene Site 1, Lancaster, California

    Locations

    30 in total

    Run by

    Inmagene LLC

    See if you can join NCT07037901 on ClinicalTrials.gov

11. Sodium in the Skin and Atopic Dermatitis

    The goal of this observational study is to understand factors associated with skin sodium storage in healthy adults and people with atopic dermatitis ages 50 and above. The study is designed to test whether diet and skin barrier function are associated with skin sodium concentration and whether ski…

    Stage

    Not phased

    Ages

    50 and older

    Site

    San Francisco VA Medical Center, San Francisco, California

    Locations

    2 in total

    Run by

    University of California, San Francisco

    See if you can join NCT06998446 on ClinicalTrials.gov

12. Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

    The main purpose of this study is to see how well different doses of soquelitinib work in participants with atopic dermatitis (AD) as compared to a placebo (pill with no medicine in it). To check this, the study doctors will examine participants' skin regularly to track how their AD changes during …

    Stage

    Phase 2

    Ages

    18 and older

    Site

    Corvus Clinical Trials, South San Francisco, California

    Run by

    Corvus Pharmaceuticals, Inc.

    See if you can join NCT07441395 on ClinicalTrials.gov

13. Flourish: Exploring the Early Infant Gut Microbiome

    The goal of this clinical trial is to learn whether microbiome analysis, education, and personalized recommendations can improve gut health and reduce early markers of immune-related conditions in infants aged 0-3 months delivered via Cesarean section. The study aims to determine whether these inte…

    Stage

    Not phased

    Ages

    0 to 0

    Site

    Seeding Labs INC, Austin, Texas

    Run by

    Seeding Inc

    See if you can join NCT07333482 on ClinicalTrials.gov

14. Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

    This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.

    Stage

    Not phased

    Ages

    18 and older

    Site

    University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

    Run by

    University of Pittsburgh

    See if you can join NCT00177268 on ClinicalTrials.gov

15. Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT

    The goal of this observational study is to learn about exposure to tralokinumab during pregnancy, as well as atopic dermatitis (AD) during pregnancy. The main question the study aims to answer is whether pregnant people who have been exposed to tralokinumab during pregnancy experience any differenc…

    Stage

    Not phased

    Ages

    Any age

    Site

    University of California San Diego (UCSD), La Jolla, California

    Run by

    University of California, San Diego

    See if you can join NCT05938478 on ClinicalTrials.gov